William Arthur

Person

Bothell, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Glypican 3 antibodies and conjugates thereof
- Patent number 11,819,553
- Issue date Nov 21, 2023
- SEAGEN INC.
- Travis Biechele
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number RE48959
- Issue date Mar 8, 2022
- SEAGEN INC.
- Maria Leia Smith
Information Patent Grant
Combinations of PBD-based antibody drug conjugates with FLT3 inhibi...
- Patent number 11,191,771
- Issue date Dec 7, 2021
- SEAGEN INC.
- William Arthur
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combinations of PBD-based antibody drug conjugates with Bcl-2 inhib...
- Patent number 11,027,021
- Issue date Jun 8, 2021
- SEAGEN INC.
- William Arthur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number 9,783,608
- Issue date Oct 10, 2017
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized antibodies to LIV-1 and use of same to treat cancer
- Patent number 9,228,026
- Issue date Jan 5, 2016
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
- Publication number 20240247059
- Publication date Jul 25, 2024
- Seagen Inc.
- Maria Leia SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20240173427
- Publication date May 30, 2024
- Seagen Inc.
- Travis Biechele
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF
- Publication number 20210361776
- Publication date Nov 25, 2021
- Seagen Inc.
- Travis Biechele
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER
- Publication number 20200165335
- Publication date May 28, 2020
- Seattle Genetics, Inc.
- Maria Leia Smith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH FLT3 INHIBI...
- Publication number 20190262354
- Publication date Aug 29, 2019
- Seattle Genetics, Inc.
- William Arthur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIB...
- Publication number 20190076549
- Publication date Mar 14, 2019
- Seattle Genetics, Inc.
- William Arthur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20180079810
- Publication date Mar 22, 2018
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20160185858
- Publication date Jun 30, 2016
- Seattle Genetics, Inc.
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
- Publication number 20130259860
- Publication date Oct 3, 2013
- Maria Leia Smith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

William Arthur

Person

Patents Grantslast 30 patents

Glypican 3 antibodies and conjugates thereof

Humanized antibodies to LIV-1 and use of same to treat cancer

Combinations of PBD-based antibody drug conjugates with FLT3 inhibi...

Combinations of PBD-based antibody drug conjugates with Bcl-2 inhib...

Humanized antibodies to LIV-1 and use of same to treat cancer

Humanized antibodies to LIV-1 and use of same to treat cancer

Patents Applicationslast 30 patents

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

HUMANIZED ANTIBODIES TO LIV-1 AND USE OF SAME TO TREAT CANCER

COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH FLT3 INHIBI...

COMBINATIONS OF PBD-BASED ANTIBODY DRUG CONJUGATES WITH BCL-2 INHIB...

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer

Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer